Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,824.66
(
0.62%
)
US TECH 100
24,372.00
(
0.53%
)
Dow Jones
48,185.80
(
0.58%
)
Brent Oil
94.24
(
-0.63%
)
Bitcoin
72,376.10
(
1.75%
)
News Focus
News Focus
Post# of 6114
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Smarttrader

Send PM Follow Ignore
Followers 46
Posts 4299
Boards Moderated 1
Alias Born 12/26/2006

Smarttrader

Re: astroguy post# 5915

Saturday, 08/22/2009 1:00:01 PM

Saturday, August 22, 2009 1:00:01 PM

Post# of 6114
This is what someone wrote on the yahoo board for CTIC, and i agree exactly with what it says!

August) priority review for Pixantrone: $4

(September) meeting regarding Opaxio: $5

(October) study results for Brostallicin: $6

(November) approval of Opaxio: $12

(November) Earnings release: $15

(December) approval of Pixantrone: $25

http://www.netcarshow.com/bmw/2007-335i_convertible/800x600/wallpaper_02.htm

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today